参考文献/References:
[1] 卓 琳,蔡卿卿,刘丁阳,等.CKD的患病率及危险因素荟萃分析[J].中国老年学杂志,2018,38(9):2135-2138.
[2] Shi Z,Zhou P,Zhang C.Prevalence of chronic kidney disease in China[J].Lancet,2012,380(9838):214.
[3] Collins AJ,Couser WG,Dirks JH,et al.World kidney day:An idea whose time has come. Developed by the International federation of kidney foundations (IFKF) and the International society of nephrology (ISN),committee for world kidney day[J]. J Am Soc NephroL,2006,17:600-601.
[4] 王 欣.世界肾脏日:重视慢性肾脏病的危害性[J].中华肾脏病杂志,2006,22(2):63-64.
[5] 丛 葳.基于“治未病”理论体系浅谈糖尿病防治应用[J].光明中医,2016,31(23):3395-3396.
[6] 王东海.《千金方》养生方药研究[D].黑龙江:黑龙江中医药大学,2017.
[7] 蔡华珠,陈建忠,洪菲萍,等.“正气存内,邪不可干”的内涵及运用探析[J]. 中华中医药杂志,2015,30(4):987-989.
[8] 潘 锋.加强慢性肾病管理要打好“四大战役”——访郑州大学第一附属医院血液净化中心王沛主任[J].中国当代医药,2018,25(3):1-3.
[9] 任永朋,卢跃卿.卢跃卿教授治疗慢性肾衰竭经验介绍[J].中医研究,2015,28(12):31-32.
[10] 王 伟,张国召,任 稹,等.尿毒症患者死亡危险因素分析[J].现代仪器与医疗,2017,23(4):58-59.
[11] 王光允,张 静,董金华.探究低盐饮食对高血压治疗的影响[J].中国卫生产业,2014,45(27):176-177.
[12] 王怡琨,傅立哲,刘 曦,等.慢性肾脏病3~5期患者对优质低蛋白饮食依从性的质性研究[J].中国中西医结合肾病杂志,2017,18(10):913-915.
[13] 樊金春.复方α酮酸治疗慢性肾衰竭45例临床观察[J].医学理论与实践,2012,25(19):2380-2381.
[14] 张 函.慢性肾脏病患者吸烟状态及其与肾脏功能和病理变化的关系研究[D].上海:复旦大学,2012.
[15] 乔红伟,张智龙.尝试以“治未病”思想指导肥胖症的干预[J].按摩与康复医学,2017,8(22):73-75.
[16] 王靖博.关于慢性肾炎的药膳食疗研究[J].光明中医,2013,28(3):447-448.
相似文献/References:
[1]刘园园,谢 胜.乾土建中三九治疗在治未病干预中的理论构建及其应用探讨[J].陕西中医,2019,(3):378.
[2]屈 凯,王悦彤,王漱非,等.基于文献研究探讨益肾散结法防治肾小球硬化的理论内涵*[J].陕西中医,2019,(7):919.
QU Kai,WANG Yuetong,WANG Shufei,et al.Based on literature research to explore the theoretical connotation of Kidney-reinforcing and Mass-disintegrating for prevention and treatment of glomerulosclerosis[J].,2019,(8):919.
[3]张宏强,李桂霞,章彩凤,等.许筠治疗慢性肾病临床药对举隅*[J].陕西中医,2020,(6):808.[doi:DOI:10.3969/j.issn.10007369.2020.06.031]
[4]陈紫薇,陈 明△.从脾论治慢性肾脏病的生物学基础探讨*[J].陕西中医,2020,(11):1627.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.029]
CHEN Ziwei,CHEN Ming..Discuss the biological foundation for chronic disease therapy from treatment through the spleen[J].,2020,(8):1627.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.029]
[5]董 怡,马 静,余楠楠,等.大黄复方保留灌肠辅助治疗慢性肾脏病疗效及对患者生活质量的影响[J].陕西中医,2021,(7):910.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.026]
DONG Yi,MA Jing,YU Nannan,et al.Effect analysis of rhubarb compound retention enema adjuvant treatment of chronic kidney disease and its impact on patients' quality of life[J].,2021,(8):910.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.026]
[6]齐 宁,宋姝西,刘香玉,等.参芪延肾方治疗慢性肾脏病疗效及对患者半乳糖缺陷IgA1、晚期糖基化终产物和微炎性反应状态的影响[J].陕西中医,2022,(5):596.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.012]
QI Ning,SONG Shuxi,LIU Xiangyu,et al.Effects of Shenqi Yanshen recipe on the levels of Gd-IgA1,AGEs and micro inflammatory response in patients with chronic kidney disease[J].,2022,(8):596.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.012]
[7]麦芳雄,张香兰,朱德礼.温肾健脾清化汤辅助治疗脾肾气虚型慢性肾脏病疗效及对患者血清转化生长因子β1、纤维连接蛋白水平的影响[J].陕西中医,2022,(8):1068.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.019]
MAI Fangxiong,ZHANG Xianglan,ZHU Deli.Clinical efficacy of Wenshen Jianpi Qinghua decoction in the treatment of chronic kidney disease with spleen-kidney qi deficiency and its effect on serum transforming growth factor β1 and fibronectin levels[J].,2022,(8):1068.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.019]
[8]杨淑彬,李 婷,李晓妮,等.不同中药结肠透析模式对慢性肾脏病患者胃肠道症状和营养状态的影响[J].陕西中医,2022,(12):1698.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.010]
YANG Shubin,LI Ting,LI Xiaoni,et al.Effects of different colon dialysis modes of traditional Chinese medicine on gastrointestinal symptoms and nutritional status in patients with chronic kidney disease[J].,2022,(8):1698.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.010]
[9]陈 曦,董凯旋,周 荣,等.中药调控p38丝裂原活化蛋白激酶/核因子κB通路治疗肾纤维化研究进展[J].陕西中医,2023,(7):980.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.036]
CHEN Xi,DONG Kaixuan,ZHOU Rong,et al.Research progress of traditional Chinese medicine regulating p38MAPK/NF-κB pathway in treatment of renal fibrosis[J].,2023,(8):980.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.036]
[10]周 林,禹 红,刘毓玲,等.活肾通络方联合依那普利对慢性肾脏病患者纤维化标志物、人附睾蛋白4水平的影响[J].陕西中医,2023,(10):1400.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.014]
ZHOU Lin,YU Hong,LIU Yuling,et al.Effect of Huoshen Tongluo decoction and enalapril on renal function,fibrosis markers and HE4 levels in patients with chronic renal disease[J].,2023,(8):1400.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.014]